(Circulation. 2002;105:497.)
© 2002 American Heart Association, Inc.
Basic Science Reports |
From Technion (Z.S.A., Y.A.), Israel Institute of Technology, Haifa, Israel; Evanston Northwestern Healthcare (V.D., P.F.), Evanston, Ill; Division of Pulmonary and Critical Care Medicine (Y.A., J.I.S., P.F.), Northwestern University, Chicago, Ill; and Universidad Católica de Chile (F.J.S.), Santiago, Chile.
Correspondence to Phillip Factor, DO, Pulmonary and Critical Care Medicine, Evanston Northwestern Healthcare, 2650 Ridge Rd, Evanston, IL 60201. E-mail pfactor{at}northwestern.edu
| Abstract |
|---|
|
|
|---|
Methods and Results Normal rats were infected with 4x109 plaque-forming units of E1a-/E3- recombinant adenoviruses that contained a cytomegalovirus promoter coupled to a rat Na,K-ATPase ß1-subunit cDNA (adß1) or no cDNA (adNull) 7 days before study. Na,K-ATPase
1- and ß1-subunit abundance in basolateral cell membranes isolated from the peripheral lung was significantly increased in adß1-infected lungs compared with sham and adNull-infected controls. In all groups, elevation of LAP reduced membrane-bound Na,K-ATPase abundance; however, abundance in adß1-infected lungs remained greater than in controls. AFC, measured with a fluid-filled isolated lung preparation in the presence of elevated LAP (15 cmH2O), in Na,K-ATPase ß1-subunit-overexpressing lungs was up to 100% greater than in controls and was not different from rats studied at normal LAP (0 cmH2O).
Conclusions These data suggest that alveolar overexpression of an Na,K-ATPase ß1-subunit can counteract downregulation of membrane-bound solute transporters owing to elevated pulmonary vascular pressures and can restore active Na+ transport and AFC in this rat model of acute hydrostatic pulmonary edema.
Key Words: epithelium genes viruses heart failure edema
| Introduction |
|---|
|
|
|---|
We have reported that adenovirus-mediated transfer of Na,K-ATPase subunit genes increases Na,K-ATPase expression and function in human and rat lung epithelial cells and the alveolar epithelium of rats.810 We have also reported that overexpression of a ß1- but not an
1-Na,K-ATPase subunit gene increases AFC by more than 100% in normal rats,9 mitigates oxidant-mediated decreases in active Na+ transport in rat fetal distal lung epithelial cells,11 and increases AFC and survival of rats exposed to 100% oxygen.8 These studies demonstrate the importance of Na,K-ATPases to vectorial Na+ transport in the lung and suggest that augmentation of Na,K-ATPase function may be useful for the treatment of pulmonary edema.
Our prior studies of the effects of Na,K-ATPase subunit gene overexpression and elevated LAP caused us to hypothesize that adenovirus-mediated gene transfer could be used to improve AFC in the setting of increased pulmonary vascular hydrostatic pressures in rats. To test this hypothesis, we infected rats with a recombinant adenovirus that expresses a rat Na,K-ATPase ß1-subunit cDNA. We then measured membrane-bound Na,K-ATPase expression and active, alveolar Na+ transport in isolated lungs with increased LAP. Herein, we report the results of the use of gene transfer to improve the ability of the lung to clear alveolar fluid in a model of acute hydrostatic pulmonary edema.
| Methods |
|---|
|
|
|---|
Isolated Lung Experiments
The isolated lung preparation was performed as described previously.2,12,13 Briefly, lungs were isolated from anesthetized rats (pentobarbital sodium 65 mg/kg IP) after a 10-minute ventilation with 100% O2 via a catheter placed through a midline tracheotomy. The pulmonary artery and left atrial appendage were cannulated and perfused with a solution of 3% BSA in buffered physiological salt solution. FITC-tagged albumin was added to the perfusate to monitor leakage of protein from the vascular space into the airways. The lungs were excised from the thoracic cavity and placed in a "pleural" bath (100 mL) filled with the same BSA solution without FITC-tagged albumin and maintained at 37°C. The lungs were then instilled via the tracheal catheter with 5 mL of BSA containing Evans blue dye (EBD)-labeled albumin, 22Na+, and 3H-mannitol. Absorbance at 620 nm (for EBD-labeled albumin), fluorescence (excitation 487 nm, emission 520 nm; for FITC-labeled albumin), and scintillation counting (for 22Na+ and 3H-mannitol) were measured in centrifuged samples from the instillate, perfusate, and bath solutions after a 10-minute equilibration period and 60 minutes later.
The derivation of all equations involved in the mathematical model of edema clearance has been described previously.13 Concentration of EBD-labeled albumin was used to estimate airspace volume. Because virtually all EBD-labeled albumin remains in the airspace, instillate volume at a given time can be calculated from the increase in airspace protein concentration. The total unidirectional flux of Na+ from the alveolar space, a result of active transport and passive movement, was calculated from the rate of loss of 22Na+ from the airspaces. Passive sodium flux was calculated by subtracting the active sodium flux, calculated from the rate of net fluid clearance, from the total. Similarly, the unidirectional volume flux of mannitol was calculated from the rate of loss of 3H-mannitol from the airspaces. Albumin flux from the pulmonary circulation into the alveolar space was determined from the fraction of FITC-labeled albumin that appeared in the alveolar instillate during the experimental protocol.
For studies of the physiological effects of elevated LAP (LAP=15 cmH2O), arterial and venous (LAP) pressures were set at 20 and 15 cmH2O, respectively, as described previously.2,3 LAP=0 cmH2O controls were studied at pressures of 15 and 0 cmH2O. The effect of elevated LAP on AFC was studied in untreated controls (n=9) and adß1-infected (n=6), adNull-infected (n=4), and sham-infected (n=4) rat lungs. These lungs were compared with untreated controls studied at LAPs of 0 cmH2O (n=10). The effect of ouabain (5x10-4 mol/L, added to the vascular perfusate) on AFC was tested in 3 to 6 animals per group.
Western Blot Analysis
Basolateral membrane (BLM) proteins were isolated14 from
1 g (wet weight) of peripheral lung tissue (ie, the distal 3 to 4 mm) that was harvested from sham-infected (n=9), adNull-infected (n=6), or adß1-infected (n=9) lungs that had been perfused against LAPs of 0 or 15 cmH2O for 60 minutes. Comparison of Na,K-ATPase ß1-subunit expression in BLMs with that in total cell membranes indicates that BLM isolation enriches Na,K-ATPase ß1-subunit levels by
3.5-fold. BLM proteins (10 *mgr;g/lane) were separated by 10% SDS-PAGE and transferred to nitrocellulose before separation of the membrane midway between the 100- and 50-kDa molecular weight markers. Membranes were then incubated with either a rabbit anti-rat ß1-Na,K-ATPase antibody (Dr Martin Vasalo, University of Tenerife, Tenerife, Spain) or a monoclonal anti-rat
1 (Upstate Biotech Inc) primary antibody. This allows for assessment of
1- and ß1-subunit levels with single Western blots. The density of the bands thus produced was quantified by a digital image-acquisition system (Eagle-eye II, Stratagene). Signal intensity was normalized to sham-infected controls.
Na,K-ATPase Function in BLMs
Triplicate samples of BLM protein (20 *mgr;g) from sham-, adNull-, and adß1-infected rats studied at normal or elevated LAP (n=6 animals/group) were resuspended in a high [Na+]/low [K+] reaction buffer (50 mmol/L NaCl, 5 mmol/L KCl) with [
-32P]-ATP as described previously.14 Na,K-ATPase activity was calculated as the difference in liberation of 32P from ATP between the test samples (total ATPase activity) and samples assayed in reaction buffer with 2.5 mmol/L ouabain and devoid of Na+ and K+ (ouabain-insensitive ATPase activity). Results were expressed as nanomoles of inorganic phosphate per milligram of protein per hour.
Statistical Analysis
Data are presented as mean±SD. One-way ANOVA (DataDesk, Data Description, Inc) was used when multiple comparisons were made. Results were considered significant at P<0.05.
| Results |
|---|
|
|
|---|
AFC in lungs treated with ouabain (5x10-4 mol/L) was not different among the groups regardless of LAP (Figure 1). We9 have previously reported that AFC in ouabain-treated adß1-infected lungs studied at an LAP of 0 cmH2O was 0.23±0.08 mL/h (n=4), which is not different from elevated-LAP adß1-infected lungs in the present study.
|
Alveolar Epithelial Permeability
The passive movement of 22Na+, 3H-mannitol from and FITC-albumin into the alveolar airspace was measured to generate an index of alveolar barrier function. Passive Na+ and mannitol flux were increased in all elevated-LAP groups compared with LAP=0 cmH2O controls (Figure 2A). Movement of the larger-molecule albumin (Figure 2B) was minimally increased in all LAP=15 cmH2O groups compared with LAP=0 cmH2O controls. Elevation of LAP did not affect pulmonary circulation flow rates or Na+ concentration (
135 mEq/mL) in the instillate, perfusate, or pleural bath in any of the isolated lung studies.
|
Na,K-ATPase Protein Abundance
To test whether acute elevations of LAP affect membrane-bound Na,K-ATPase abundance, cell membrane fractions enriched for the BLM domain were prepared from peripheral lung tissue after 60 minutes of perfusion of the pulmonary vasculature at LAPs of 15 or 0 cmH2O. Semiquantitative (Western) analysis from 6 to 9 animals per group revealed higher levels of both Na,K-ATPase
1- and ß1-subunits in adß1-infected lungs than in similarly perfused sham- and adNull-infected lungs (Figure 3). Intragroup comparison indicated that LAP elevation was associated with reductions of
1-subunit levels in all groups compared with similarly infected normal LAP specimens (Figure 3B). Acute LAP elevation reduced ß1-subunit protein expression in the sham and adß1 groups (Figure 3A). AdNull-infected lungs demonstrated a trend toward reduction of ß1-subunit abundance that did not reach statistical significance.
|
Membrane-bound Na,K-ATPase activity was quantified by measurement of ouabain-sensitive ATP hydrolysis (Na,K-ATPase activity) by BLMs isolated from the peripheral lung of rats studied at LAPs of 0 and 15 cmH2O for 60 minutes (Figure 4). Activity was measured in the presence of low [K+]/high [Na+] and ATP to maximize ATPase function per molecule (Vmax) and produce a quantitative index of membrane-bound receptor number. These experiments revealed that Na,K-ATPase activity fell by
35% to 45% in the setting of elevated LAP in all groups (Figure 4). Na,K-ATPase function in BLMs from adß1-infected lungs studied at normal or elevated LAP was greater than that in all other groups.
|
| Discussion |
|---|
|
|
|---|
In the present study, we observed that acute elevation of LAP was associated with diminution of both Na,K-ATPase activity and abundance in BLMs isolated from peripheral lung tissue (Figures 3 and 4). Data from our group and other investigators indicate that bidirectional movement of assembled Na,K-ATPase heterodimers from intracellular pools contributes to the short-term regulation of Na,K-ATPase function.1820 Given these prior data and the results of the present study, we speculate that acute elevation of pulmonary vascular pressures (left atrial hypertension) decreases the number of Na,K-ATPases in the plasma membrane and that this loss of transporters impairs fluid reabsorption and contributes to the pathophysiology of hydrostatic pulmonary edema. This hypothesis is supported by the observation that increasing Na,K-ATPase abundance in BLMs normalizes AFC. Taken together, our data suggest that Na,K-ATPase gene transfer improves AFC in this model of acute lung injury by increasing functional Na,K-ATPase levels in the cell membrane. Interestingly, clearance rates in the adß1 lungs, although not different from those in normal LAP controls, were less than that measured in our prior studies8,9 of ß1-subunit overexpression (1.09±0.09 mL/h) in normal rats. We speculate that this may be due to continued movement of fluid along hydrostatic pressure gradients out of the vascular space, although we cannot exclude that other epithelial transport proteins may be dysfunctional in this model. In addition, our model only allows insight into the acute effects of LAP elevation on alveolar active Na+ transport. Sustained elevation of LAP, as would be expected in chronic congestive heart failure, might be associated with markedly different changes in alveolar transport protein expression and function.
We used an established surfactant-based delivery system and viral dose that is capable of widespread gene transfer to the alveolar epithelium of rats.8,9 The duration of recovery (7 days) was based on past studies and was intended to maximize transgene function while allowing time for vector-induced host responses to subside.9 Alveolar permeability in all of the elevated-LAP groups in the present study was increased to a level similar to that in our prior reports of the effects of increased LAP on AFC.2,3 Alveolar barrier function in the adNull- and adß1-infected lungs was not different from similarly treated uninfected and sham-infected controls (Figure 2), which suggests that adenoviral infection does not compound changes in permeability in this model. We believe that the changes in permeability seen with elevated pulmonary capillary hydrostatic pressures in the present study may be due to stretch-induced pore formation and/or capillary stress failure.21,22 Similar findings of increased permeability in a rabbit model of hydrostatic pulmonary edema have been reported by Bachofen et al.23,24 Importantly, the mild increases in alveolar permeability noted in the present study were less than those noted in our prior studies of lung injury4,8 and did not impede assessment of AFC.
Prior data indicate that Na,K-ATPases are predominantly expressed in the basolateral plasma membranes of alveolar epithelial cells25,26 and that our adenovector delivery system preferentially targets the alveolar epithelium.8,9 The BLMs used in the present study were isolated from peripheral lung tissue and included membranes from all polarized cells in the distal lung (ie, alveolar epithelium and endothelium). The inclusion of proteins from this heterogeneous mix of cells may dilute alveolar epithelial proteins and lead to underestimation of the abundance and function of alveolar epithelial solute transport proteins. An alternate approach would be to isolate alveolar type 2 epithelial cells. However, doing so would exclude any contribution of type 1 epithelial cells and would preclude isolation of BLMs because of loss of cell polarity during cell isolation. We believe that the significant increases in Na,K-ATPase function and
1- and ß1-subunit expression in BLMs from the peripheral lung of adß1-infected animals corroborate our AFC data (Figure 1) and support the notion that peripheral lung tissue can be used to gain useful insights into the regulation of alveolar epithelial solute transport proteins.
We have previously shown9,27 that adenovirus-mediated gene transfer of a rat ß1-cDNA to rat lungs significantly increases ß1-subunit protein expression in the alveolar epithelium. In the present study, we observed increases in ß1-protein expression in BLMs from adß1-infected lungs, which indicates that gene transfer increases ß1-subunit levels in the appropriate domain of the cell membrane. Our prior studies showed that
1-subunit overexpression does not increase active transport in rat alveolar cells or lungs, which caused us to hypothesize that the ß1-subunit is rate-limiting in the rat lung. The finding of increased
1-subunit expression in BLMs from adß1-infected lungs in the present study and prior in vitro data allow us to speculate that ß1-subunit overexpression increases membrane-bound Na,K-ATPase levels via recruitment of
1/ß1-heterodimers from intracellular pools.18 Whether ß1-subunit overexpression affects
1-subunit gene transcription or translation rates was not tested in the present study.
The data presented in this report support the paradigm that acute elevation of LAP impairs active Na+ transport in part by downregulating transport proteins in the cell membrane. The results of the present study show for the first time that gene transfer can increase Na,K-ATPase transport protein abundance and function and restore AFC in this model of acute hydrostatic pulmonary edema. The ability of adenovectors to transduce the alveoli of acutely injured edematous rat lungs28,29 allows us to propose the use of genetic therapies to counterbalance the pathophysiological impairment of alveolar active Na+ transport seen in the setting of acute left atrial hypertension.
| Acknowledgments |
|---|
Received June 14, 2001; revision received November 12, 2001; accepted November 14, 2001.
| References |
|---|
|
|
|---|
2.
Saldias FJ, Azzam ZS, Ridge KM, et al. Alveolar fluid reabsorption is impaired by increased left atrial pressures in rats. Am J Physiol (Lung Cell Mol Physiol). 2001; 281: L591L597.
3.
Azzam ZS, Saldias FJ, Comellas A, et al. Catecholamines increase lung edema clearance in rats with increased left atrial pressure. J Appl Physiol. 2001; 90: 10881094.
4. Olivera W, Ridge K, Sznajder J. Lung liquid clearance and Na,K-ATPase during acute hyperoxia and recovery in rats. Am J Respir Crit Care Med. 1995; 152: 12291234.[Abstract]
5. Carter EP, Wangensteen OD, Dunitz J, et al. Hyperoxic effects on alveolar sodium resorption and lung Na-K-ATPase. Am J Physiol. 1997; 273: L1191L1202.
6.
Verghese GM, Ware LB, Matthay BA, et al. Alveolar epithelial fluid transport and the resolution of clinically severe hydrostatic pulmonary edema. J Appl Physiol. 1999; 87: 13011312.
7.
Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001; 163: 13761383.
8. Factor P, Dumasius V, Saldias F, et al. Adenovirus-mediated transfer of an Na+/K+-ATPase ß1 subunit gene improves alveolar fluid clearance and survival in hyperoxic rats. Hum Gene Ther. 2000; 11: 22312242.[CrossRef][Medline] [Order article via Infotrieve]
9. Factor P, Saldias F, Ridge K, et al. Augmentation of lung liquid clearance via adenoviral-mediated gene transfer of the Na,K-ATPase ß1 subunit. J Clin Invest. 1998; 102: 11421150.[Medline] [Order article via Infotrieve]
10.
Factor P, Senne C, Dumasius V, et al. Overexpression of the Na,K-ATPase
1 subunit increases Na,K-ATPase function in A549 cells. Am J Respir Cell Mol Biol. 1998; 18: 741749.
11.
Thome U, Chen L, Factor P, et al. Na,K-ATPase gene transfer mitigates an oxidant-induced decrease of active sodium transport in rat fetal ATII cells. Am J Respir Cell Mol Biol. 2001; 24: 245252.
12.
Barnard ML, Ridge KM, Saldias F, et al. Stimulation of the dopamine 1 receptor increases lung edema clearance. Am J Respir Crit Care Med. 1999; 160: 982986.
13.
Rutschman DH, Olivera W, Sznajder JI. Active transport and passive liquid movement in isolated perfused rat lungs. J Appl Physiol. 1993; 75: 15741580.
14.
Dumasius V, Sznajder JI, Azzam ZS, et al. ß2-Adrenergic receptor overexpression increases alveolar fluid clearance and responsiveness to endogenous catecholamines in rat. Circ Res. 2001; 89: 907914.
15.
Campbell AR, Folkesson HG, Berthiaume Y, et al. Alveolar epithelial fluid clearance persists in the presence of moderate left atrial hypertension in sheep. J Appl Physiol. 1999; 86: 139151.
16. Saldias F, Azzam Z, Comellas A, et al. Lung ability to clear edema is impaired by high hydrostatic pulmonary circulation pressures. Am J Respir Crit Care Med. 1999; 159: A604.
17. Raj JU, Bland RD. Lung luminal liquid clearance in newborn lambs: effect of pulmonary microvascular pressure elevation. Am Rev Respir Dis. 1986; 134: 305310.[Medline] [Order article via Infotrieve]
18. Lecuona E, Garcia A, Sznajder JI. A novel role for protein phosphatase 2A in the dopaminergic regulation of Na,K-ATPase. FEBS Lett. 2000; 481: 217220.[CrossRef][Medline] [Order article via Infotrieve]
19.
Yudowski GA, Efendiev R, Pedemonte CH, et al. Phosphoinositide-3 kinase binds to a proline-rich motif in the Na+, K+-ATPase alpha subunit and regulates its trafficking. Proc Natl Acad Sci U S A. 2000; 97: 65566561.
20.
Ogimoto G, Yudowski GA, Barker CJ, et al. G protein-coupled receptors regulate Na+,K+-ATPase activity and endocytosis by modulating the recruitment of adaptor protein 2 and clathrin. Proc Natl Acad Sci U S A. 2000; 97: 32423247.
21.
West JB, Mathieu-Costello O. Vulnerability of pulmonary capillaries in heart disease. Circulation. 1995; 92: 622631.
22. West JB, Mathieu-Costello O. Structure, strength, failure, and remodeling of the pulmonary blood-gas barrier. Annu Rev Physiol. 1999; 61: 543572.[CrossRef][Medline] [Order article via Infotrieve]
23. Bachofen H, Schurch S, Michel RP, et al. Experimental hydrostatic pulmonary edema in rabbit lungs. Morphol Am Rev Respir Dis. 1993; 147: 989996.
24. Bachofen H, Schurch S, Weibel ER. Experimental hydrostatic pulmonary edema in rabbit lungs: barrier lesions. Am Rev Respir Dis. 1993; 147: 9971004.[Medline] [Order article via Infotrieve]
25. Schneeberger E, McCarthy K. Cytochemical localization of Na,K-ATPase in rat type II pneumocytes. J Appl Physiol. 1986; 20: 15841589.
26.
Nici L, Dowin R, Gilmore-Hebert M, et al. Upregulation of rat lung Na-K-ATPase during hyperoxic injury. Am J Physiol. 1991; 261: L307L314.
27.
Factor P, Ridge K, Alverdy J, et al. Continuous enteral nutrition attenuates pulmonary edema in rats exposed to 100% oxygen. J Appl Physiol. 2000; 89: 17591765.
28. Factor P, Mendez M, Mutlu G, et al. Acute hyperoxic lung injury does not impede adenoviral-mediated alveolar gene transfer. Am J Respir Crit Care Med. In press.
29. Weiss DJ, Bonneau L, Liggitt D. Use of perfluorochemical liquid allows earlier detection of gene expression and use of less vector in normal lung and enhances gene expression in acutely injured lung. Mol Ther. 2001; 3: 734745.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
E. Baloglu, A. Ke, I. H. Abu-Taha, P. Bartsch, and H. Mairbaurl In vitro hypoxia impairs {beta}2-adrenergic receptor signaling in primary rat alveolar epithelial cells Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L500 - L509. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Adir, L. C. Welch, V. Dumasius, P. Factor, J. I. Sznajder, and K. M. Ridge Overexpression of the Na-K-ATPase {alpha}2-subunit improves lung liquid clearance during ventilation-induced lung injury Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1233 - L1237. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zhou, L. A. Dada, and J. I. Sznajder Regulation of alveolar epithelial function by hypoxia Eur. Respir. J., May 1, 2008; 31(5): 1107 - 1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Mutlu and P. Factor Alveolar Epithelial 2-Adrenergic Receptors Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 127 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, J. Xu, G. Ma, M. Sagawa, M. Shimazaki, Y. Ueda, and T. Sakuma Chronic pulmonary artery occlusion increases alveolar fluid clearance in rats. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1213 - 1219. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Guney, A. Schuler, A. Ott, S. Hoschele, S. Zugel, E. Baloglu, P. Bartsch, and H. Mairbaurl Dexamethasone prevents transport inhibition by hypoxia in rat lung and alveolar epithelial cells by stimulating activity and expression of Na+-K+-ATPase and epithelial Na+ channels Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1332 - L1338. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Mutlu, D. Machado-Aranda, J. E. Norton, A. Bellmeyer, D. Urich, R. Zhou, and D. A. Dean Electroporation-mediated Gene Transfer of the Na+,K+-ATPase Rescues Endotoxin-induced Lung Injury Am. J. Respir. Crit. Care Med., September 15, 2007; 176(6): 582 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Agostoni, M. Contini, G. Cattadori, A. Apostolo, S. Sciomer, M. Bussotti, P. Palermo, and C. Fiorentini Lung function with carvedilol and bisoprolol in chronic heart failure: Is {beta} selectivity relevant? Eur J Heart Fail, August 1, 2007; 9(8): 827 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Randrianarison, B. Escoubet, C. Ferreira, A. Fontayne, N. Fowler-Jaeger, C. Clerici, E. Hummler, B. C. Rossier, and C. Planes beta-Liddle mutation of the epithelial sodium channel increases alveolar fluid clearance and reduces the severity of hydrostatic pulmonary oedema in mice J. Physiol., July 15, 2007; 582(2): 777 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Azzam, Y. Adir, L. Welch, J. Chen, J. Winaver, P. Factor, N. Krivoy, A. Hoffman, J. I. Sznajder, and Z. Abassi Alveolar fluid reabsorption is increased in rats with compensated heart failure Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L1094 - L1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Litvan, A. Briva, M. S. Wilson, G. R. S. Budinger, J. I. Sznajder, and K. M. Ridge beta-Adrenergic Receptor Stimulation and Adenoviral Overexpression of Superoxide Dismutase Prevent the Hypoxia-mediated Decrease in Na,K-ATPase and Alveolar Fluid Reabsorption J. Biol. Chem., July 21, 2006; 281(29): 19892 - 19898. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Mutlu and J. I. Sznajder Mechanisms of pulmonary edema clearance Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L685 - L695. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Myrianthefs, A. Briva, E. Lecuona, V. Dumasius, D. H. Rutschman, K. M. Ridge, G. J. Baltopoulos, and J. I. Sznajder Hypocapnic but Not Metabolic Alkalosis Impairs Alveolar Fluid Reabsorption Am. J. Respir. Crit. Care Med., June 1, 2005; 171(11): 1267 - 1271. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Mutlu, Y. Adir, M. Jameel, A. T. Akhmedov, L. Welch, V. Dumasius, F. J. Meng, J. Zabner, C. Koenig, E. R. Lewis, et al. Interdependency of {beta}-Adrenergic Receptors and CFTR in Regulation of Alveolar Active Na+ Transport Circ. Res., May 13, 2005; 96(9): 999 - 1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Vadasz, R. E. Morty, M. G. Kohstall, A. Olschewski, F. Grimminger, W. Seeger, and H. A. Ghofrani Oleic Acid Inhibits Alveolar Fluid Reabsorption: A Role in Acute Respiratory Distress Syndrome? Am. J. Respir. Crit. Care Med., March 1, 2005; 171(5): 469 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Mutlu, W. J. Koch, and P. Factor Alveolar Epithelial {beta}2-Adrenergic Receptors: Their Role in Regulation of Alveolar Active Sodium Transport Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1270 - 1275. [Full Text] [PDF] |
||||
![]() |
G. M. Mutlu, V. Dumasius, J. Burhop, P. J. McShane, F. J. Meng, L. Welch, A. Dumasius, N. Mohebahmadi, G. Thakuria, K. Hardiman, et al. Upregulation of Alveolar Epithelial Active Na+ Transport Is Dependent on {beta}2-Adrenergic Receptor Signaling Circ. Res., April 30, 2004; 94(8): 1091 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Sloniewsky, K. M. Ridge, Y. Adir, F. P. Fries, A. Briva, J. I. Sznajder, and P. H. S. Sporn Leukotriene D4 Activates Alveolar Epithelial Na,K-ATPase and Increases Alveolar Fluid Clearance Am. J. Respir. Crit. Care Med., February 1, 2004; 169(3): 407 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Adir, P. Factor, V. Dumasius, K. M. Ridge, and J. I. Sznajder Na,K-ATPase Gene Transfer Increases Liquid Clearance during Ventilation-induced Lung Injury Am. J. Respir. Crit. Care Med., December 15, 2003; 168(12): 1445 - 1448. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.M. Ridge, W.G. Olivera, F. Saldias, Z. Azzam, S. Horowitz, D.H. Rutschman, V. Dumasius, P. Factor, and J.I. Sznajder Alveolar Type 1 Cells Express the {alpha}2 Na,K-ATPase, Which Contributes to Lung Liquid Clearance Circ. Res., March 7, 2003; 92(4): 453 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. I. Sznajder, P. Factor, and D. H. Ingbar Lung Edema Clearance: 20 Years of Progress: Invited Review: Lung edema clearance: role of Na+-K+-ATPase J Appl Physiol, November 1, 2002; 93(5): 1860 - 1866. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Fisher and S. S. Margulies Na+-K+-ATPase activity in alveolar epithelial cells increases with cyclic stretch Am J Physiol Lung Cell Mol Physiol, October 1, 2002; 283(4): L737 - L746. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |